Evaluating cell lines as models for metastatic breast cancer through integrative analysis of genomic data
While cell lines and organoids are extensively used to study cancer, how closely they resemble the disease in patients remains unclear. Here, Liu et al. shed light on this issue by comparing the genomic and transcriptomic profiles of different breast cancer cell lines and organoids to data from pati...
Guardado en:
Autores principales: | Ke Liu, Patrick A. Newbury, Benjamin S. Glicksberg, William Z. D. Zeng, Shreya Paithankar, Eran R. Andrechek, Bin Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7eb9424dafc04cdfaba1f2ce0b7d5375 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer
por: I. Blancas, et al.
Publicado: (2021) -
Genomic landscape of extraordinary responses in metastatic breast cancer
por: Sun Min Lim, et al.
Publicado: (2021) -
Metastasis is altered through multiple processes regulated by the E2F1 transcription factor
por: Matthew R. Swiatnicki, et al.
Publicado: (2021) -
Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer
por: A. Migeotte, et al.
Publicado: (2021) -
Integrated analyses of murine breast cancer models reveal critical parallels with human disease
por: Jonathan P. Rennhack, et al.
Publicado: (2019)